Year-end Sale % OFF 
Abstract
Allergic rhinitis (AR) is a common global disease, affecting approximately 2%–25% of children and 1%–40% of adults. Recent studies have shown an increasing prevalence, especially in low-income countries. Although not fatal, AR significantly impairs patients’ quality of life and is linked to bronchial asthma (BA) development. This research aimed to study the regional distribution of AR in children, analyze various medicine preparations used for treatment, and identify effective and affordable options through pharmaco-economic methods. Data from the Ministry of Healthcare of the Republic of Uzbekistan, Hospital No. 2 of the Tashkent Medical Academy, and wholesale medicine costs were analyzed. The study demonstrated the effectiveness and cost efficiency of budesonide medicines for treating AR in children with BA, resulting in significant cost savings during the first treatment session.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
